A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants

Since the first case of Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019, SARS-CoV-2 infection has affected many individuals worldwide. Eventually, some highly infectious mutants—caused by frequent genetic recombination—have been reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabaan, Ali A., Mutair, Abbas Al, Hajissa, Khalid, Alfaraj, Amal H., Al-Jishi, Jumana M., Alhajri, Mashael, Alwarthan, Sara, Alsuliman, Shahab A., Al-Najjar, Amal H., Al Zaydani, Ibrahim A., Al-Absi, Ghadeer Hassan, Alshaikh, Sana A., Alkathlan, Mohammed S., Almuthree, Souad A., Alawfi, Abdulsalam, Alshengeti, Amer, Almubarak, Fatimah Z., Qashgari, Mohammed S., Abdalla, Areeg N. K., Alhumaid, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611209/
https://www.ncbi.nlm.nih.gov/pubmed/36298520
http://dx.doi.org/10.3390/vaccines10101655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611209/
https://www.ncbi.nlm.nih.gov/pubmed/36298520
http://dx.doi.org/10.3390/vaccines10101655

Ejemplares similares